Las formulaciones actuales aprobadas por la FDA incluyen semaglutida, dulaglutida, liraglutida, exenatida y tirzepatida (un agonista dual GLP-1/GIP)
The drug works by activating both GIP and GLP-1 receptors, a dual mechanism that reduces appetite, slows gastric emptying, improves insulin sensitivity, and enhances fat metabolism
To promote long-term weight maintenance, the use of approved weight loss medication (over no pharmacological therapy) is suggested to ameliorate comorbidities and amplify adherence to behavior changes, which may improve physical functioning and allow for greater physical activity in individuals with a BMI of 30 kg/m 2 or higher or in individuals with a BMI of 27 kg/m 2 and at least one associated comorbid medical condition
Semaglutide ELITE Service - $1800 for 16 weeks ($450/mo) 16 weeks of weekly Semaglutide injections + FREE access to our Fitness and Nutrition Program
Take a moment to set personal limits
Suggested Use: Take 1/4 level teaspoon 1 to 3 times daily